Medwell Capital to Present at Rodman & Renshaw Annual Global Investment
Conference

EDMONTON, Sept. 9 /CNW/ - Medwell Capital Corp. (TSX: MWC) today announced that Mr. Kevin Giese, President and CEO, will present at the Rodman & Renshaw Annual Global Investment Conference in New York City.

"We are pleased to present our new corporate strategy at this year's global investment conference. The team we have assembled at Medwell represents a deep and broad range of experience ideally suited to assist healthcare companies in achieving success and creating value," said Kevin Giese, President and CEO of Medwell Capital. "In addition to access to capital, many healthcare companies require carefully planned regulatory, capital markets, partnering and commercialization strategies and Medwell is well-positioned to deliver these critical elements. Medwell Capital remains focused on investing our financial and management resources in promising opportunities in order to realize shareholder value."

WHEN: Monday September 13, 2010 at 3:40 pm (Eastern Time)

WHERE: The Palace Hotel New York

An archived version of the power point will be available following the presentation at the Company's web site.

    
    About Medwell Capital Corp.
    ---------------------------
    

Medwell Capital Corp. is a Canadian-based provider of capital and advisory services for the healthcare industry. For further information please visit www.medwellcapital.com.

This press release may contain forward-looking statements, which reflect the Company's current expectation regarding future events. These forward-looking statements involve risks and uncertainties that may cause actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward-looking statements. Such factors include, but are not limited to, changing market conditions, the successful and timely completion of clinical studies, the establishment of corporate alliances, the impact of competitive products and pricing, new product development, uncertainties related to the regulatory approval process and other risks detailed from time to time in the Corporation's ongoing quarterly and annual reporting. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

For further information: Tony Hesby, Ryan Giese, Medwell Capital Corp., 780-413-7152, 780-408-3040 Fax, E-mail: [email protected], Internet: http://www.medwellcapital.com; James Smith, Investor Relations, 416-815-0700 ext. 229, 416-815-0080 Fax, E-mail: [email protected]